The California-based Lyell is expected to pay up to $30m in cash along with shar...
The funds will be used to advance Agomab’s candidates through clinical trials, i...
Dyno has formed a new research partnership with Roche on the development of AAV ...
There are already two FDA-approved gene therapies for haemophilia B courtesy of ...
Darzalex will now be available to patients with newly diagnosed multiple myeloma...
Abrysvo is now approved to prevent lower respiratory tract disease caused by RSV...
Ocuphire Pharma has announced the acquisition of Opus Genetics to develop gene t...
The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the...
This NMA serves to bridge the gap between trials for both therapies and compare ...
Servier Canada has announced Health Canada's approval of VORANIGO for Grade 2 ID...
A year after the first samRNA vaccine approval, experts say others are likely to...
The companies have presented positive Phase II data during an oral session at ID...
The UK’s National Institute of Health and Care Excellence (NICE) said the drug p...
Common conditions in women such as PCOS, menopause, and endometriosis often lead...
Novartis is investing over $70 million in Chengdu Baiyu Pharmaceutical to bolste...
In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the ben...
